SCHEMBL39693

SCHEMBL39693

C[Si](C)(C)CCOCNc1cc(C2CCC(=O)CC2)nc2ccnn12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE10A Q9Y233 3/20 0.50
MAPKAPK2 P49137 3/20 0.36
KCNN3 Q9UGI6 4/20 0.35
CDK9 P50750 8/20 0.35
CCNT1 O60563 7/20 0.35
CDK7 P50613 5/20 0.35
CDK2 P24941 4/20 0.35
CCNH P51946 4/20 0.35
CDK1 P06493 3/20 0.35
CDK4 P11802 3/20 0.35
CCNA2 P20248 3/20 0.35
CCND1 P24385 3/20 0.35
CCNE1 P24864 3/20 0.35
CCNA1 P78396 3/20 0.35
CDK3 Q00526 3/20 0.35
CDK6 Q00534 2/20 0.35
CDK13 Q14004 1/20 0.35
CDK12 Q9NYV4 1/20 0.35
KCNN1 Q92952 1/20 0.34
KCNN2 Q9H2S1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL47770 0.91 PDE10A (0.49) PDE10AMAPKAPK2KCNN3CDK9CCNT1
SCHEMBL10209999 0.88 PDE10A (0.53) PDE10AMAPKAPK2KCNN3CDK9CCNT1
SCHEMBL10210928 0.87 PDE10A (0.49) PDE10AMAPKAPK2KCNN3CDK9CCNT1
SCHEMBL20682 0.80 PDE10A (0.34) PDE10ACDK9CDK7CDK2CCNA2
SCHEMBL19818 0.78 PDE10A (0.41) PDE10AMAPKAPK2KCNN3CDK9CCNT1
SCHEMBL45705 0.78 KCNN3 (0.57) PDE10AKCNN3KCNN1KCNN2
SCHEMBL7879251 0.75 KCNN3 (0.38) PDE10AMAPKAPK2KCNN3CDK2KCNN1
SCHEMBL7887263 0.75 PDE10A (0.41) PDE10AMAPKAPK2KCNN3CDK9CCNT1
SCHEMBL2679823 0.75 CRHR1 (0.32) PDE10ACDK2CCNA2CCNA1
SCHEMBL7874462 0.74 CCNT1 (0.43) CDK9CCNT1CDK7CDK2CCNH

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012027234-A1 FUSED TRICYCLIC INHIBITORS OF MAMMALIAN TARGET OF RAPAMYCIN SCHERING CORPORATION (US) 2012-03-01 WO disclosed